Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Sexual dysfunction in men treated with depot antipsychotic drugs: a pilot study

David Plevin A , Cherrie Galletly A B C and Penny Roughan A B
+ Author Affiliations
- Author Affiliations

A Discipline of Psychiatry, University of Adelaide, The Adelaide Clinic, 33 Park Terrace, Gilberton, Adelaide, SA 5081, Australia.

B Central Northern Adelaide Health Service, Northern Division, 63 Commercial Road, Salisbury, South Australia, SA 5112, Australia.

C Corresponding author. Email: cherrie.galletly@adelaide.edu.au

Sexual Health 4(4) 269-271 https://doi.org/10.1071/SH07012
Submitted: 27 February 2007  Accepted: 6 October 2007   Published: 23 November 2007

Abstract

Background: Sexual dysfunction is common, but often under-recognised, in people with schizophrenia. Many antipsychotic drugs are known to cause prolactin elevation, and it is often assumed that sexual dysfunction is a consequence of prolactin elevation. We investigated the relationship between sexual function and serum concentrations of prolactin and testosterone in men receiving regular long-acting depot injections of antipsychotic medication. Methods: Twenty-two men attending a community depot clinic participated. A structured interview was used to collect information about sexual function, and serum prolactin and testosterone concentrations were measured. Results: Sexual dysfunction was common, with 73% of men reporting problems in at least one area of sexual function. Six men had elevated serum prolactin and one had reduced serum testosterone. Antipsychotic drug dose was positively correlated with serum prolactin and negatively correlated with serum testosterone, but there was no association between serum prolactin or testosterone concentrations and any measure of sexual dysfunction. Conclusion: Sexual dysfunction is a major problem for men living with chronic schizophrenia, but our results suggest that it is not directly attributable to elevated prolactin or reduced testosterone concentrations.

Additional keywords: erectile dysfunction, libido, typical antipsychotic drugs.


Acknowledgements

This research was supported by a University of Adelaide Student Summer Scholarship. We would like to acknowledge the assistance of Ms Bev Howland and the Northern Mental Health Research Unit.


References


[1] Fortier P,  Mottard JP,  Trudel G,  Even S. Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull 2003; 29 559–72.
PubMed |

[2] Ng ML,  Ho R. Erectile function of Chinese men with schizophrenia in psychiatric out-patient clinics and their attitude towards treatment. Sex Health 2004; 1 35–8.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[3] Conner P,  Fried G. Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta Obstet Gynecol Scand 1998; 77 249–62.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[4] Akhondzadeh S,  Rezaei F,  Larijani B,  Nejatisafa AA,  Kashani L,  Abbasi SH. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res 2006; 84 405–10.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[5] McGahuey CA,  Gelenberg AJ,  Laukes CA,  Moreno FA,  Delgado PL,  McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26 25–40.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[6] Jablensky A,  McGrath J,  Herrman H,  Castle D,  Gureje O,  Evans M, et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Aust N Z J Psychiatry 2000; 34 221–36.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[7] Dossenbach M,  Dyachkova Y,  Pirildar S,  Anders M,  Khalil A,  Araszkiewicz A, et al. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006; 21 251–8.
Crossref | GoogleScholarGoogle Scholar | PubMed |

[8] Gopalakrishnan R,  Jacob KS,  Kuruvilla A,  Vasantharaj B,  John JK. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry 2006; 163 494–9.
Crossref | GoogleScholarGoogle Scholar | PubMed |